Logistical challenges and assumptions for modeling the failure of global cessation of oral poliovirus vaccine (OPV)

by Kimberly M. Thompson, Dominika A. Kalkowska
Published 2019-07-01

Polio health economics: assessing the benefits and costs of polio, non-polio, and integrated activities of the Global Polio Eradication Initiative [version 1; peer review: 2 approv...

by Kimberly M. Thompson, Kamran Badizadegan, Dominika A. Kalkowska
Published 2022-02-01

Oral polio vaccine stockpile modeling: insights from recent experience

by Kimberly M. Thompson, Dominika A. Kalkowska, Kamran Badizadegan
Published 2023-12-01

Looking back at prospective modeling of outbreak response strategies for managing global type 2 oral poliovirus vaccine (OPV2) cessation

by Kimberly M. Thompson, Dominika A. Kalkowska, Kamran Badizadegan
Published 2023-03-01

Another look at silent circulation of poliovirus in small populations

by Dominika A. Kalkowska, Radboud J. Duintjer Tebbens, Kimberly M. Thompson
Published 2018-01-01

Complexity of options related to restarting oral poliovirus vaccine (OPV) in national immunization programs after OPV cessation [version 1; peer review: 1 approved, 2 approved with...

by Steven GF Wassilak, Dominika A Kalkowska, Concepcion F Estivariz, Eric Wiesen, Kimberly M Thompson, Cara C Burns, Kamran Badizadegan
Published 2023-04-01

Associations between pneumonia and residential distance to livestock farms over a five-year period in a large population-based study.

by Dominika A Kalkowska, Gert Jan Boender, Lidwien A M Smit, Christos Baliatsas, Joris Yzermans, Dick J J Heederik, Thomas J Hagenaars
Published 2018-01-01

Modeling undetected poliovirus circulation following the 2022 outbreak in the United States

by Dominika A. Kalkowska, Kamran Badizadegan, Janell A. Routh, Cara C. Burns, Eli S. Rosenberg, I. Ravi Brenner, Jane R. Zucker, Marisa Langdon-Embry, Kimberly M. Thompson
Published 2024-12-01